Cargando…

Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder

While double-blinding is a crucial aspect of study design in an interventional clinical trial of medication for a disorder with subjective endpoints such as major depressive disorder, psychotherapy clinical trials, particularly cognitive-behavioral therapy trials, cannot be double-blinded. This pape...

Descripción completa

Detalles Bibliográficos
Autor principal:	Berger, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Clinical Practice Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732552/ https://www.ncbi.nlm.nih.gov/pubmed/26870318 http://dx.doi.org/10.12688/f1000research.6953.2

Ejemplares similares

Double blinding requirement for validity claims in cognitive-behavioral therapy intervention trials for major depressive disorder. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial
por: Berger, Douglas
Publicado: (2015)

Cognitive Behavioral Therapy for Depression
por: Gautam, Manaswi, et al.
Publicado: (2020)

Association between AKT1 gene polymorphisms and depressive symptoms in the Chinese Han population with major depressive disorder★
por: Yang, Chunxia, et al.
Publicado: (2012)

The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population★
por: Li, Xinrong, et al.
Publicado: (2012)

Preventive Effect of Liothyronine on Electroconvulsive Therapy-Induced Memory Deficit in Patients with Major Depressive Disorder: A Double-Blind Controlled Clinical Trial
por: Mohagheghi, Arash, et al.
Publicado: (2015)

Clinical Practice Guidelines for Cognitive Behavioral Therapy for Psychotic Disorders
por: Avasthi, Ajit, et al.
Publicado: (2020)

No association between a polymorphism of the adenylate cyclase type IX gene and major depressive disorder in the Chinese Han population☆
por: Cao, Suxia, et al.
Publicado: (2012)

Clinical Practice Guidelines for Cognitive-Behavioral Therapies in Anxiety Disorders and Obsessive-Compulsive and Related Disorders
por: Reddy, Y. C. Janardhan, et al.
Publicado: (2020)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
por: Zuilhof, Zoë, et al.
Publicado: (2018)

Modelling cognitive affective biases in major depressive disorder using rodents
por: Hales, Claire A, et al.
Publicado: (2014)

Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial
por: Guimarães, Mara C., et al.
Publicado: (2021)

Effectiveness of Meta-Cognitive and Cognitive-Behavioral Therapy in Patients with Major Depressive Disorder
por: Ashouri, Ahmad, et al.
Publicado: (2013)

The Effect of Internet-Based Cognitive Behavioral Therapy on Major Depressive Disorder: Randomized Controlled Trial
por: Lin, Ziyi, et al.
Publicado: (2023)

Embodied simulation in exposure-based therapies for posttraumatic stress disorder—a possible integration of cognitive behavioral theories, neuroscience, and psychoanalysis
por: Peri, Tuvia, et al.
Publicado: (2015)

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
por: Hashemi, SN, et al.
Publicado: (2012)

Effectiveness of low-dose amitriptyline and mirtazapine for insomnia disorder: study protocol of a randomised, double-blind, placebo-controlled trial in general practice (the DREAMING study)
por: Bakker, Mette H, et al.
Publicado: (2021)

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
por: von Rotz, Robin, et al.
Publicado: (2022)

Quality of Life and Medication Adherence in Patients With Major Depressive Disorder: An Interim Analysis of a Randomized Study
por: Santi, N Simple, et al.
Publicado: (2023)

Treating posttraumatic stress disorder remotely with cognitive therapy for PTSD
por: Wild, Jennifer, et al.
Publicado: (2020)

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials
por: Thase, Michael E., et al.
Publicado: (2017)

Effects of cognitive-behavioral therapy on neurotrophic factors in patients with major depressive disorder
por: da Silva, Sally K., et al.
Publicado: (2018)

Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression
por: Rapaport, Mark H., et al.
Publicado: (2002)

Vortioxetine in the treatment of adult patients with major depressive disorder: a meta-analysis of randomized double-blind controlled trials
por: Berhan, Asres, et al.
Publicado: (2014)

Double-Blind Randomized Clinical Trial of the Efficacy of Venlafaxine Versus Citalopram in the Treatment of the Acute Phase of Major Depressive Disorder
por: Hosseini, Fatemeh, et al.
Publicado: (2015)

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
por: Montgomery, Stuart A., et al.
Publicado: (2014)

Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
por: Durgam, Suresh, et al.
Publicado: (2018)

Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
por: Fava, Maurizio, et al.
Publicado: (2018)

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
por: Pérez, Víctor, et al.
Publicado: (2017)

Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2021)

Quality of reporting and risk of bias: a review of randomised trials in occupational health
por: Tikka, Christina, et al.
Publicado: (2021)

Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019)

Bright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double-blind, controlled clinical trial
por: Bais, Babette, et al.
Publicado: (2016)

Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
por: von Rotz, Robin, et al.
Publicado: (2023)

Efficacy of the LED Red Light Therapy in the Treatment of Temporomandibular Disorders: Double Blind Randomized Controlled Trial
por: Al-Quisi, Ahmed Fadhel, et al.
Publicado: (2019)

Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial
por: WANG, Zhiyang, et al.
Publicado: (2015)

Double-blind, placebo-controlled trial of mifepristone on cognition and depression in alcohol dependence
por: Donoghue, Kim, et al.
Publicado: (2020)

A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder
por: Sinha, Shubhadeep, et al.
Publicado: (2021)

Online Mindfulness-Based Cognitive Behavioral Therapy Intervention for Youth With Major Depressive Disorders: Randomized Controlled Trial
por: Ritvo, Paul, et al.
Publicado: (2021)

The effect of cognitive behavioral therapy on future thinking in patients with major depressive disorder: A randomized controlled trial
por: Amano, Mizuki, et al.
Publicado: (2023)

Addressing risk of bias in trials of cognitive behavioral therapy
por: BUTTON, Katherine S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3hnp4qjv1taf3iqooim3q34pfu